This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Westendorp, B. Articles by van Gilst, W. H Search for Related Content PubMed PubMed Citation Articles by Westendorp, B. Articles by van Gilst, W. H Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CAPTOPRIL Medline Plus Health Information Diets Heart Attack Social Bookmarking                         What's this?

Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction

Department of Clinical Pharmacology, University of Groningen, The Netherlands, b.westendorp{at}med.rug.nl

Regien G Schoemaker

Department of Clinical Pharmacology, University of Groningen, The Netherlands, Department of Cardiology, University Hospital Groningen, The Netherlands

Hendrik Buikema

Department of Clinical Pharmacology, University of Groningen, The Netherlands

Dick de Zeeuw

Department of Clinical Pharmacology, University of Groningen, The Netherlands

Dirk J van Veldhuisen

Department of Cardiology, University Hospital Groningen, The Netherlands

Wiek H van Gilst

Department of Clinical Pharmacology, University of Groningen, The Netherlands, Department of Cardiology, University Hospital Groningen, The Netherlands

Introduction In patients with myocardial infarction (MI)-induced heart failure, angiotensin-converting enzyme (ACE) inhibitors are proven effective therapy in inhibiting the progression towards overt heart failure. However, the prognosis in these patients is still very poor, and optimisation of therapy is warranted. The antihypertensive and renoprotective effects of ACE inhibitors (ACE-Is) can be substantially enhanced by dietary sodium restriction. In line with the latter, the aim of the present study was to explore whether dietary sodium restriction enhances the efficacy of ACE-I after MI.

Methods Rats with MI-induced left ventricular (LV) dysfunction received ACE-I therapy with zofenopril (5.5 mg/kg/day orally), with or without dietary sodium restriction. ACE activity was measured in non-infarcted LV tissue, kidneys and plasma. Effects on cardiac hypertrophy were examined by means of organ weight/body weight ratios. After blood pressure (BP) measurements, functional consequences of therapy were evaluated as LV pressure development in isolated perfused hearts.

Results Dietary sodium restriction alone had no effect on any of the measured parameters, whereas zofenopril alone significantly reduced plasma and kidney ACE activity, but not LV ACE activity, nor LV weight/body weight ratio. However, only when ACE-I therapy was combined with dietary sodium restriction was LV ACE activity significantly reduced. This effect was paralleled by inhibition of LV hypertrophy. BP was reduced after infarction, and further reduced by zofenopril, but not affected by dietary sodium. Neither treatment was associated with effects on the MI-induced reduction of LV function in vitro.

Conclusions Effects of ACE inhibition with zofenopril can be potentiated by additional dietary sodium restriction. However, these effects were tissue-specific, since LV, but not kidney or plasma, ACE activity was affected by the additional dietary sodium restriction. Effects on LV ACE activity were paralleled by reduced LV hypertrophy. Since the measured parameters did not indicate any adverse side-effects, dietary sodium restriction may provide a safe strategy to improve ACE-I efficacy in patients with infarction-induced LV dysfunction.

Key Words: myocardial infarction • ACE inhibition • dietary sodium restriction • hypertrophy

References

• Kober L.,Torp-Pedersen C., Carlsen JE et al.A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 1995;333:1670-6.[Abstract/Free Full Text]
• Flather MD,Yusuf S., Kober L. et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000;355:1575-81.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Brogden RN,Todd PA, Sorkin EM Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Drugs 1988;36:540-600.[Web of Science][Medline] [Order article via Infotrieve]
• Cleland JG, Erhardt L., Murray G., Hall AS, Ball SG Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure.A report from the AIRE Study Investigators. Eur Heart J 1997;18:41-51.[Web of Science][Medline] [Order article via Infotrieve]
• Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991;325:293-302.[Abstract]
• Konstam MA, Rousseau MF, Kronenberg MW et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. Circulation 1992;86:431-8.[Abstract/Free Full Text]
• Navis G., de Jong P., Donker AJ, van der Hem GK, de Zeeuw D. Diuretic effects of angiotensin-converting enzyme inhibition: comparison of low and liberal sodium diet in hypertensive patients. J Cardiovasc Pharmacol 1987;9:743-8.[Web of Science][Medline] [Order article via Infotrieve]
• Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 1989;36:272-9.[Web of Science][Medline] [Order article via Infotrieve]
• Gansevoort RT, Wapstra FH, Weening JJ, de Jong PE, de Zeeuw D. Sodium depletion enhances the antiproteinuric effect of ACE inhibition in established experimental nephrosis. Nephron 1992;60:246-7.[Web of Science][Medline] [Order article via Infotrieve]
• Fernandez D., Bolli P., Snedden W., Vasdev S., Fernandez PG Modulation of left ventricular hypertrophy by dietary salt and inhibition of angiotensin converting enzyme. J Hypertens 1988;6(suppl):S145-S147.[Web of Science]
• Buter H., Hemmelder MH, Navis G., de Jong PE, de Zeeuw D. The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide. Nephrol Dial Transplant 1998;13:1682-5.[Abstract/Free Full Text]
• Pinto YM, de Smet BG, van Gilst WH et al. Selective and time related activation of the cardiac renin-angiotensin system after experimental heart failure: relation to ventricular function and morphology. Cardiovasc Res 1993;27:1933-8.[Abstract/Free Full Text]
• Pfeffer MA, Pfeffer JM, Fishbein MC et al. Myocardial infarct size and ventricular function in rats. Circ Res 1979;44:503-12.[Abstract/Free Full Text]
• Nelissen-Vrancken HJ, Kuizinga MC, Daemen MJ, Smits JF Early captopril treatment inhibits DNA synthesis in endothelial cells and normalization of maximal coronary flow in infarcted rat hearts. Cardiovasc Res 1998;40:156-64.[Abstract/Free Full Text]
• Schoemaker RG, Debets JJ, Struyker-Boudier HA, Smits JF Delayed but not immediate captopril therapy improves cardiac function in conscious rats, following myocardial infarction. J Mol Cell Cardiol 1991;23:187-97.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Cushman DW, Cheung HS Concentrations of angiotensin-converting enzyme in tissues of the rat. Biochim Biophys Acta 1971;250:261-5.[Medline] [Order article via Infotrieve]
• Seeland U., Kouchi I., Zolk O. et al. Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post-myocardial infarction in rats. EurJHeartFail 2003;5:241-6.
• Sun Y., Weber KT Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J Mol Cell Cardiol 1996;28:851-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Sun Y., Cleutjens JP, Diaz-Arias AA, Weber KT Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res 1994;28:1423-32.[Abstract/Free Full Text]
• van Wijngaarden J., Pinto YM, van Gilst WH, de Graeff PA, de Langen CD, Wesseling H. Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril. Cardiovasc Res 1991; 25:936-42.[Abstract/Free Full Text]
• Wollert KC, Studer R., von Bulow B., Drexler H. Survival after myocardial infarction in the rat. Role of tissue angiotensinconverting enzyme inhibition. Circulation 1994;90:2457-67.[Abstract/Free Full Text]
• Hodsman GP, Sumithran E., Harrison RW, Johnston CI Cardiac hypertrophy and salt status in chronic myocardial infarction in the rat:effects of enalapril versus salt restriction. J Cardiovasc Pharmacol 1988;12:467-72.[Web of Science][Medline] [Order article via Infotrieve]
• Kreutz R., Fernandez-Alfonso MS, Liu Y., Ganten D., Paul M. Induction of cardiac angiotensin I-converting enzyme with dietary NaCl-loading in genetically hypertensive and normotensive rats. J Mol Med 1995;73:243-8.[Web of Science][Medline] [Order article via Infotrieve]
• Schmid C., Castrop H., Reitbauer J., Della BR, Kurtz A. Dietary salt intake modulates angiotensin II type 1 receptor gene expression.Hypertension 1997;29:923-9.[Abstract/Free Full Text]
• Nickenig G., Strehlow K., Roeling J., Zolk O., Knorr A., Bohm M. Salt induces vascular AT1 receptor overexpression in vitro and in vivo. Hypertension 1998;31:1272-7.[Abstract/Free Full Text]
• Ruan X.,Wagner C., Chatziantoniou C., KurtzA.,Arendshorst WJ Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet. J Clin Invest 1997;99:1072-81.[Web of Science][Medline] [Order article via Infotrieve]
• McEwan PE, Gray GA, Sherry L., Webb DJ, Kenyon CJ Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo. Circulation 1998;98:2765-73.[Abstract/Free Full Text]
• Regitz-Zagrosek V., Fielitz J., Fleck E. Myocardial angiotensin receptors in human hearts. Basic Res Cardiol 1998;93(suppl 2):37-42.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Yoshida K., Kohzuki M., Casley DJ, Johnston CI Angiotensin-converting enzyme inhibition and salt in experimental myocardial infarction. J Cardiovasc Pharmacol 1998;32:357-65.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Teisman AC, Pinto YM, Buikema H. et al. Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats. J Hypertens 1998;16(12 Pt 1):1759-65.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kalkman EA, Saxena PR, Schoemaker RG Sensitivity to ischemia of chronically infarcted rat hearts; effects of long-term captopril treatment. Eur J Pharmacol 1996;298:121-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mill JG, Gomes AP, Carrara AB, Gomes MG, Vassallo DV Influence of chronic captopril therapy on the mechanical performance of the infarcted rat heart. Pharmacol Res 1994; 29:77-88.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mitchell GF, Lamas GA, Vaughan DE, Pfeffer MA Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape. J Am Coll Cardiol 1992; 19:1136-44.[Abstract]
• Pfeffer MA, Braunwald E. Ventricular enlargement following infarction is a modifiable process. Am J Cardiol 1991; 68:127D-131D.[CrossRef][Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 5, No. 1, 27-32 (2004)
DOI: 10.3317/jraas.2004.004


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Westendorp, B. Articles by van Gilst, W. H Search for Related Content PubMed PubMed Citation Articles by Westendorp, B. Articles by van Gilst, W. H Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CAPTOPRIL Medline Plus Health Information Diets Heart Attack Social Bookmarking                         What's this?